BlackRock’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.9M | Sell |
4,010,755
-536,397
| -12% | -$1.99M | ﹤0.01% | 3137 |
|
|
2025
Q1 | $14.7M | Sell |
4,547,152
-374,169
| -8% | -$1.21M | ﹤0.01% | 3073 |
|
|
2024
Q4 | $27.4M | Buy |
4,921,321
+52,532
| +1% | +$293K | ﹤0.01% | 2802 |
|
|
2024
Q3 | $52.6M | Sell |
4,868,789
-28,108
| -0.6% | -$304K | ﹤0.01% | 2411 |
|
|
2024
Q2 | $103M | Buy |
4,896,897
+612,349
| +14% | +$12.9M | ﹤0.01% | 2000 |
|
|
2024
Q1 | $137M | Buy |
4,284,548
+819,961
| +24% | +$26.1M | ﹤0.01% | 1859 |
|
|
2023
Q4 | $70.2M | Buy |
3,464,587
+340,911
| +11% | +$6.91M | ﹤0.01% | 2250 |
|
|
2023
Q3 | $39.8M | Buy |
3,123,676
+209,246
| +7% | +$2.66M | ﹤0.01% | 2496 |
|
|
2023
Q2 | $52.7M | Buy |
2,914,430
+363,695
| +14% | +$6.57M | ﹤0.01% | 2402 |
|
|
2023
Q1 | $43.8M | Buy |
2,550,735
+42,103
| +2% | +$724K | ﹤0.01% | 2493 |
|
|
2022
Q4 | $55.7M | Buy |
2,508,632
+278,233
| +12% | +$6.18M | ﹤0.01% | 2364 |
|
|
2022
Q3 | $17.9M | Buy |
2,230,399
+47,641
| +2% | +$383K | ﹤0.01% | 3047 |
|
|
2022
Q2 | $15.2M | Buy |
2,182,758
+52,532
| +2% | +$367K | ﹤0.01% | 3180 |
|
|
2022
Q1 | $32.2M | Buy |
2,130,226
+42,544
| +2% | +$643K | ﹤0.01% | 2811 |
|
|
2021
Q4 | $45.8M | Buy |
2,087,682
+649,319
| +45% | +$14.2M | ﹤0.01% | 2675 |
|
|
2021
Q3 | $38.8M | Buy |
1,438,363
+706,953
| +97% | +$19.1M | ﹤0.01% | 2798 |
|
|
2021
Q2 | $17.6M | Buy |
731,410
+184,006
| +34% | +$4.43M | ﹤0.01% | 3323 |
|
|
2021
Q1 | $23.7M | Buy |
547,404
+541,476
| +9,134% | +$23.5M | ﹤0.01% | 3037 |
|
|
2020
Q4 | $246K | Buy |
+5,928
| New | +$246K | ﹤0.01% | 4367 |
|